Study Of Asthma In Patients Of African Descent

PHASE4CompletedINTERVENTIONAL
Enrollment

479

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

April 30, 2007

Study Completion Date

April 30, 2007

Conditions
Asthma
Interventions
DRUG

fluticasone propionate/salmeterol powder

DRUG

fluticasone propionate powder

Trial Locations (75)

10032

GSK Investigational Site, New York

11215

GSK Investigational Site, Brooklyn

11796

GSK Investigational Site, West Sayville

19102

GSK Investigational Site, Philadelphia

19107

GSK Investigational Site, Philadelphia

19406

GSK Investigational Site, Jenkintown

20010

GSK Investigational Site, Washington D.C.

20060

GSK Investigational Site, Washington D.C.

20814

GSK Investigational Site, Bethesda

21236

GSK Investigational Site, Baltimore

23225

GSK Investigational Site, Richmond

23229

GSK Investigational Site, Richmond

23507

GSK Investigational Site, Norfolk

23601

GSK Investigational Site, Newport News

27103

GSK Investigational Site, Winston-Salem

27262

GSK Investigational Site, High Point

27599

GSK Investigational Site, Chapel Hill

27710

GSK Investigational Site, Durham

27909

GSK Investigational Site, Elizabeth City

28204

GSK Investigational Site, Charlotte

29118

GSK Investigational Site, Orangeburg

29407

GSK Investigational Site, Charleston

29607

GSK Investigational Site, Greenville

30030

GSK Investigational Site, Decatur

30342

GSK Investigational Site, Atlanta

30907

GSK Investigational Site, Martinez

31406

GSK Investigational Site, Savannah

31904

GSK Investigational Site, Columbus

32205

GSK Investigational Site, Jacksonville

32308

GSK Investigational Site, Tallahassee

35205

GSK Investigational Site, Birmingham

35209

GSK Investigational Site, Birmingham

35662

GSK Investigational Site, Muscle Shoals

36106

GSK Investigational Site, Montgomery

36608

GSK Investigational Site, Mobile

37208

GSK Investigational Site, Nashville

37421

GSK Investigational Site, Chattanooga

37909

GSK Investigational Site, Knoxville

37920

GSK Investigational Site, Knoxville

39202

GSK Investigational Site, Jackson

39466

GSK Investigational Site, Picayune

43560

GSK Investigational Site, Sylvania

44106

GSK Investigational Site, Cleveland

45231

GSK Investigational Site, Cincinnati

48197

GSK Investigational Site, Ypsilanti

48201

GSK Investigational Site, Detroit

53792

GSK Investigational Site, Madison

55455

GSK Investigational Site, Minneapolis

60422

GSK Investigational Site, Flossmoor

60637

GSK Investigational Site, Chicago

63110

GSK Investigational Site, St Louis

70006

GSK Investigational Site, Metairie

70503

GSK Investigational Site, Lafayette

70584

GSK Investigational Site, Sunset

72204

GSK Investigational Site, Little Rock

72205

GSK Investigational Site, Little Rock

73120

GSK Investigational Site, Oklahoma City

75230

GSK Investigational Site, Dallas

75246

GSK Investigational Site, Dallas

77054

GSK Investigational Site, Houston

78750

GSK Investigational Site, Austin

90048

GSK Investigational Site, Los Angeles

90806

GSK Investigational Site, Long Beach

92506

GSK Investigational Site, Riverside

93551

GSK Investigational Site, Palmdale

94102

GSK Investigational Site, San Francisco

94598

GSK Investigational Site, Walnut Creek

95207

GSK Investigational Site, Stockton

35294-0012

GSK Investigational Site, Birmingham

06105

GSK Investigational Site, Hartford

02114

GSK Investigational Site, Boston

07044

GSK Investigational Site, Verona

19104-6160

GSK Investigational Site, Philadelphia

29406-7108

GSK Investigational Site, Charleston

37203-1424

GSK Investigational Site, Nashville

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY